Discontinuación y adherencia a largo plazo en la terapia con interferón beta en pacientes con esclerosis múltiple

treatment of MS patients with IFNβ is discontinued mainly due to lack of efficacy and adverse effects. Greater understanding of patients' views can help to identify those at greatest risk of lack of adherence, thereby helping to improve treatment.